# Primerica Reports First Quarter 2026 Results
Canonical URL: https://biopharmsignal.com/news/PRI/primerica-reports-first-quarter-2026-results
Ticker: PRI
Company: PRIMERICA
Source: PRIMERICA
Published: 2026-05-06 20:15 EST
Original Source URL: https://investors.primerica.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-15 20:15 EST — [Primerica Schedules Second Quarter 2026 Financial Results Webcast](https://biopharmsignal.com/news/PRI/primerica-schedules-second-quarter-2026-financial-results-webcast-8557ad05) — Source: PRIMERICA
- 2026-06-30 04:00 EST — [PRIMERICA HOUSEHOLD BUDGET INDEX™ (HBI™): Gas Prices Continued to Weigh on Purchasing Power of Middle-Income Families in May](https://biopharmsignal.com/news/PRI/primerica-household-budget-index-hbi-gas-prices-continued-to-weigh-on-purchasing-cd4ad354) — Source: PRIMERICA
- 2026-06-11 14:00 EST — [Survey Reveals 85% of Canadians Trust Professional Financial Advice Over Social Media “Finfluencers”](https://biopharmsignal.com/news/PRI/survey-reveals-85-of-canadians-trust-professional-financial-advice-over-social-m-49637e88) — Source: PRIMERICA
- 2026-05-28 04:00 EST — [PRIMERICA HOUSEHOLD BUDGET INDEX™ (HBI™): Rising Gas Prices Limit Purchasing Power of Middle-Income Americans in April](https://biopharmsignal.com/news/PRI/primerica-household-budget-indextm-hbitm-rising-gas-prices-limit-purchasing-power-of-middle-income-americans-in-april) — Source: PRIMERICA
- 2026-05-06 20:15 EST — [Primerica Reports First Quarter 2026 Results](https://biopharmsignal.com/news/PRI/primerica-reports-first-quarter-2026-results) — Source: PRIMERICA
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)